| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 10/16/2026 | ±3.3% | +2.1% | over-priced |
| 06/18/2026 | ±4.8% | -18.0% | under-priced |
| 03/19/2026 | ±3.3% | +4.3% | under-priced |
| 12/18/2025 | ±2.5% | -1.4% | over-priced |
| 10/10/2025 | ±2.0% | -4.4% | under-priced |
| 06/20/2025 | ±1.8% | -6.9% | under-priced |
| 03/20/2025 | ±2.1% | -7.3% | under-priced |
| 12/19/2024 | ±2.0% | +7.1% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q4 FY2026 | $3.29 | $18.7B | $2.0B |
| Q3 FY2026 | $3.80 | $18.7B | $2.3B |
| Q2 FY2026 | $2.93 | $18.0B | $1.8B |
| Q1 FY2026 | $3.54 | $18.7B | $2.2B |
ACN (ACN) reports in 83 days, with the next report estimated for 01/18/2027. Across the last 8 reports, options priced an average ±2.7% earnings move while the stock actually moved 6.4% on average — the market has tended to under-price ACN's earnings risk. Fundamentals into the print: EPS up 46.2% year-over-year, revenue up 6.2%. QuantLogix's live 5-factor engine currently reads ACN as a buy at 78/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →